HCPCS Level IIdrugActive
J7173
Inj. concizumab-mtci, 0.5 mg
BETOS: O1E
Effective: 2025-10-01
Description
Injection, concizumab-mtci, 0.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Alhemo
Manufacturer
Novo Nordisk, Inc
HCPCS Dosage
0.5 MG
Billing Units
300.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.